Fredun Pharmaceuticals Ltd (BOM:539730)

Q3 2026 Fredun Pharmaceuticals Ltd Earnings Call Transcript

Feb 12, 2026 / 06:30 AM GMT

Release Date Price: ₹608.68 (-3.00%)

Transcript

Key Points

Positve

Fredun Pharmaceuticals Ltd (BOM:539730) reported a strong Q3 FY26 total income of 160.92 crore, reflecting a 57% year-on-year growth.
EBITDA for the quarter showed a robust growth of 99% year-on-year, reaching 26.34 crore.
Net profit for the quarter nearly doubled with a growth of 96% year-on-year, standing at 10.48 crore.
The company has successfully launched new brands in the last 2-3 years, contributing significantly to its growth.
The pet care and nutraceutical segments are performing well, with the pet care business expected to show revenue from the current quarter onwards.

Negative

The company anticipates a need for additional funding in the next 12 to 18 months if growth continues at the current pace.
Finance costs have increased due to new machinery loans and changes in banking partners.
The company's guidance is conservative, which may not fully reflect the potential growth opportunities.
There is a seasonal fluctuation in sales, with the last quarter typically being the strongest, which may affect margin consistency.
The company faces challenges in launching products across multiple states simultaneously, which could impact the speed of market penetration.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

FRED.BO - Fredun Pharmaceuticals Ltd
Q3 2026 Fredun Pharmaceuticals Ltd Earnings Call
Feb 12, 2026 / 06:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to Q3 and 9 months FY26 results conference call of Freedom Pharmaceutical Limited hosted by Kieran Advisors Private Limited. As a reminder, all participant lines will be in listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing, then 0 on your touchstone phone. Please note that this conference is being recorded.

I now hand over the call to Miss Sahi Manjiiara from Kitten Advisors Private Limited.

Thank you and over to you, ma'am.

------------------------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.